|
|
|
| Effects of Nimodipine Combined with Sodium Valproate on Hemodynamic Parameters Inflammatory Factors and Neurological Function in Patients with Acute Cerebral Hemorrhage |
| LIANG Shuang, TUEERHONG·Tuerxun, LIU Bo |
| The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Urumqi 830000, China |
|
|
|
|
Abstract Objective: To observe the effects of nimodipine combined with sodium valproate on hemodynamic parameters, inflammatory factors and neurological function in patients with acute cerebral hemorrhage.Methods: 160 patients with acute cerebral hemorrhage were divided into observation group and control group according to the simple random grouping, with 80 cases in each group. The two groups were given conventional neurological treatment, and control group was given sodium valproate, and observation group was combined with nimodipine on the basis of control group. The neurological function [National Institutes of Health Stroke Scale (NIHSS), neuron-specific enolase (NSE)], hemodynamic parameters [mean flow velocity (Vm), peak systolic blood velocity (Vs), pulsatility index (PI), resistance index (RI) ], intracranial state-related indicators (intracranial pressure, intracranial hematoma volume) and levels of inflammatory factors [interleukin-6 (IL-6), tumor necrosis factor (TNF-α), high-sensitivity C-reactive protein (hs-CRP)] were compared between the two groups before treatment and after 2 weeks of treatment, and the safety of medication was evaluated through adverse reactions after treatment. Results: After 2 weeks of treatment, the NIHSS scale score, NSE, RI, intracranial pressure, intracranial hematoma volume, and levels of IL-6, TNF-α and hs-CRP in the two groups showed downward trends compared with those before treatment (all P<0.05), and the decreases were greater in observation group (P<0.05). The levels of Vm, Vs and PI showed upward trends compared with those before treatment (all P<0.05), and the increases were greater in observation group (P<0.05). There was no statistically significant differences in the total incidence rate of adverse reactions between the two groups (χ2=0.132, P=0.717). Conclusion: Nimodipine combined with sodium valproate can effectively improve cerebral blood perfusion and promote the recovery of neurological function in patients with acute cerebral hemorrhage, and can further reduce the inflammatory response and further lower intracranial pressure and intracranial hematoma volume. And it is favorable to disease outcomes.
|
|
|
|
|
|
[1] 丛蓓,罗金维,韩世杰,等.脑出血患者临床流行病学调查[J].临床医学进展,2019,9(6):751~755.
[2] 徐占义,张亚召,赵旺淼,等.尼莫地平对高血压脑出血治疗的研究[J].检验医学与临床,2017,14(Z1):289~290.
[3] Hesami O,Sistanizad M,Asadollahzade E,et al.Comparing the effects of atorvastatin with sodium valproate (divalproex) on frequency and intensity of frequent migraine headaches: a double-blind randomized controlled study[J].Clinical Neuropharmacology,2018,41(3):94~97.
[4] 王辉,时代音,胡春婷,等.丙戊酸钠联合尼莫地平治疗急性脑出血的疗效观察及对神经功能和Tf、GFAP水平的影响[J].解放军预防医学杂志,2019,37(8):96~97,102.
[5] 王春华,许丽,陈祥,等.依达拉奉联合尼莫地平对脑出血患者氧化应激以及神经功能的影响[J].广西医科大学学报,2018,35(2):209~212.
[6] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国脑出血诊治指南(2019)[J].中华神经科杂志,2019,52(12):994~1005.
[7] 赵晓晶,李群喜,刘英,等.美国国立卫生院脑卒中量表评分与脑出血患者预后的相关性探讨[J].中国临床医生杂志,2019,47(6):86~88.
[8] Z.-R.Li.Cerebral hemorrhage treatment drug edaravone showed inhibition effect towards drug-metabolizing enzymes (Dmes)[J].Latin American Journal of Pharmacy,2017,36(7):1328~1330.
[9] 毛妮,张蕾,邹真真.依达拉奉联合神经节苷脂治疗对急性脑出血患者NOET和血液流变学指标的影响[J].河北医学,2017,23(7):1154~1158.
[10] 刘德浪,顾勇,刘卫花.依达拉奉佐治急性脑梗死并脑微出血对患者神经功能及氧化应激指标的影响[J].中国药业,2020,29(14):44~46.
[11] 张秋菊,贾茹,王亚娟,等.神经外科病人预防癫痫发生的用药分析[J].安徽医药,2017,21(3):563~565.
[12] 李云峰,卢丹丹,欧阳方.尼莫地平对老年高血压脑出血患者神经功能及血清AQP4、MIF水平的影响[J].心血管康复医学杂志,2019,28(5):643~647.
[13] 徐兵,龚筱倩,刘庆华.依达拉奉联合尼莫地平治疗对高血压脑出血患者炎性因子和神经功能的影响[J].临床误诊误治,2019,32(3):36~39. |
|
|
|
2021, Vol. 27 
